2013
Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis
King M, Essick C, Bearman P, Ross JS. Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis. The BMJ 2013, 346: f264. PMID: 23372175, PMCID: PMC3623604, DOI: 10.1136/bmj.f264.Peer-Reviewed Original ResearchMeSH KeywordsAntidepressive AgentsAntipsychotic AgentsCase-Control StudiesCentral Nervous System StimulantsCyclohexanolsDesvenlafaxine SuccinateDextroamphetamineDrug IndustryGift GivingHealth Care SectorHumansInterprofessional RelationsIsoxazolesMarketing of Health ServicesOrganizational PolicyPaliperidone PalmitatePractice Patterns, Physicians'Psychotropic DrugsPyrimidinesSchools, MedicalUnited StatesConceptsPsychotropic medicationsSubsequent prescribing behaviorPhysician prescribingPsychotropic classesOlder antipsychoticsPrescribing behaviorMAIN OUTCOMEMedicationsMedical schoolsPrescribingPhysiciansAntipsychoticsRestriction policiesDesvenlafaxinePaliperidoneStimulantsUS medical schoolsExposureLonger exposureAntidepressantsCohort
2010
Physician Attitudes Toward Industry: A View Across the Specialties
Korenstein D, Keyhani S, Ross JS. Physician Attitudes Toward Industry: A View Across the Specialties. JAMA Surgery 2010, 145: 570-577. PMID: 20566978, PMCID: PMC2891545, DOI: 10.1001/archsurg.2010.75.Peer-Reviewed Original ResearchMeSH KeywordsAcademic Medical CentersAdultAttitude of Health PersonnelConflict of InterestCross-Sectional StudiesDrug IndustryEquipment and SuppliesEthics, MedicalFemaleGeneral SurgeryGift GivingHumansInterprofessional RelationsMaleMarketingMiddle AgedMultivariate AnalysisNew York CityPractice Patterns, Physicians'Surveys and QuestionnairesTotal Quality Management
2009
Appropriateness of Collaborations between Industry and the Medical Profession: Physicians' Perceptions
Ross JS, Keyhani S, Korenstein D. Appropriateness of Collaborations between Industry and the Medical Profession: Physicians' Perceptions. The American Journal Of Medicine 2009, 122: 955-960. PMID: 19786162, PMCID: PMC3020980, DOI: 10.1016/j.amjmed.2009.04.013.Peer-Reviewed Original ResearchMeSH KeywordsAcademic Medical CentersAttitude of Health PersonnelChi-Square DistributionConflict of InterestCross-Sectional StudiesDelivery of Health CareDrug IndustryEquipment and SuppliesFemaleHospitals, UniversityHumansInternal MedicineInterprofessional RelationsMaleNew York CityPhysician's RolePrivate SectorProbabilitySurveys and QuestionnairesRelationships with the drug industry: More regulation, greater transparency
Krumholz HM, Ross JS. Relationships with the drug industry: More regulation, greater transparency. The BMJ 2009, 338: b211. PMID: 19193612, DOI: 10.1136/bmj.b211.Commentaries, Editorials and Letters
2008
Updated Estimates of Pharmaceutical Company Payments to Physicians in Vermont
Ross JS, Nazem AG, Lurie P, Lackner JE, Krumholz HM. Updated Estimates of Pharmaceutical Company Payments to Physicians in Vermont. JAMA 2008, 300: 1998-2000. PMID: 18984886, DOI: 10.1001/jama.2008.560.Peer-Reviewed Original Research
2007
Pharmaceutical Company Payments to Physicians: Early Experiences With Disclosure Laws in Vermont and Minnesota
Ross JS, Lackner JE, Lurie P, Gross CP, Wolfe S, Krumholz HM. Pharmaceutical Company Payments to Physicians: Early Experiences With Disclosure Laws in Vermont and Minnesota. JAMA 2007, 297: 1216-1223. PMID: 17374816, DOI: 10.1001/jama.297.11.1216.Peer-Reviewed Original ResearchWhat have we learnt from Vioxx?
Krumholz HM, Ross JS, Presler AH, Egilman DS. What have we learnt from Vioxx? The BMJ 2007, 334: 120. PMID: 17235089, PMCID: PMC1779871, DOI: 10.1136/bmj.39024.487720.68.Commentaries, Editorials and Letters